Drugs used in platelet disorders (Formulary)

ELTROMBOPAG

Important: Therapy notes

MHRA advice: Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results (July 2018) (www.gov.uk).

Important: Formulation and dosage details

Formulation:

Tablets 25mg, 50mg (hospital use only)

ROMIPLOSTIM

Important: Therapy notes


Risk minimisation materials

Important: Formulation and dosage details

Formulation:

Injection 250 micrograms (hospital use only)

ANAGRELIDE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Capsules 500 micrograms (specialist initiation)

Editorial Information

Document Id: F291